These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 26838894)
1. Enhanced conjugation stability and blood circulation time of macromolecular gadolinium-DTPA contrast agent. Jenjob R; Kun N; Ghee JY; Shen Z; Wu X; Cho SK; Lee DH; Yang SG Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():659-64. PubMed ID: 26838894 [TBL] [Abstract][Full Text] [Related]
2. The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI. Yim H; Yang SG; Jeon YS; Park IS; Kim M; Lee DH; Bae YH; Na K Biomaterials; 2011 Aug; 32(22):5187-94. PubMed ID: 21561660 [TBL] [Abstract][Full Text] [Related]
3. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA. Yoshikawa K; Inoue Y; Akahane M; Shimada M; Itoh S; Seno A; Hayashi S J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid. Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent. Wang X; Feng Y; Ke T; Schabel M; Lu ZR Pharm Res; 2005 Apr; 22(4):596-602. PubMed ID: 15846467 [TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MR angiography in rats with hepatobiliary contrast agents. Yoshikawa K; Inoue Y; Shimada M; Akahane M; Itoh S; Seno A; Hayashi S Magn Reson Imaging; 2004 Sep; 22(7):937-42. PubMed ID: 15288134 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212 [TBL] [Abstract][Full Text] [Related]
9. Speciation of Gd-based MRI contrast agents and potential products of transmetalation with iron ions or parenteral iron supplements. Telgmann L; Wehe CA; Künnemeyer J; Bülter AC; Sperling M; Karst U Anal Bioanal Chem; 2012 Nov; 404(8):2133-41. PubMed ID: 23001305 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model. Feng Y; Zong Y; Ke T; Jeong EK; Parker DL; Lu ZR Pharm Res; 2006 Aug; 23(8):1736-42. PubMed ID: 16850267 [TBL] [Abstract][Full Text] [Related]
11. Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy. Haar PJ; Broaddus WC; Chen ZJ; Fatouros PP; Gillies GT; Corwin FD Phys Med Biol; 2010 Jun; 55(12):3451-65. PubMed ID: 20508321 [TBL] [Abstract][Full Text] [Related]
12. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739 [TBL] [Abstract][Full Text] [Related]
14. Dextran gadolinium complexes as contrast agents for magnetic resonance imaging to sentinel lymph nodes. Yan GP; Xu W; Yang L; Li L; Liu F; Guo QZ Pharm Res; 2010 Sep; 27(9):1884-92. PubMed ID: 20559699 [TBL] [Abstract][Full Text] [Related]
16. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Tsuda N; Okada M; Murakami T Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431 [TBL] [Abstract][Full Text] [Related]
17. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer. Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435 [TBL] [Abstract][Full Text] [Related]
18. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine. Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243 [TBL] [Abstract][Full Text] [Related]